Raffles Medical Group Ltd

DB:02M1 Rapporto sulle azioni

Cap. di mercato: €1.2b

Raffles Medical Group Crescita futura

Future criteri di controllo 1/6

Raffles Medical Group is forecast to grow earnings and revenue by 12.6% and 4% per annum respectively. EPS is expected to grow by 10.9% per annum. Return on equity is forecast to be 7.3% in 3 years.

Informazioni chiave

12.6%

Tasso di crescita degli utili

10.9%

Tasso di crescita dell'EPS

Healthcare crescita degli utili23.1%
Tasso di crescita dei ricavi4.0%
Rendimento futuro del capitale proprio7.3%
Copertura analitica

Good

Ultimo aggiornamento02 Nov 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Previsioni di crescita degli utili e dei ricavi

DB:02M1 - Stime future degli analisti e dati finanziari passati (SGD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2026821831061235
12/31/2025785781001238
12/31/202474169-8988
6/30/2024703617297N/A
3/31/202470676120143N/A
12/31/202370890167189N/A
9/30/2023747117166189N/A
6/30/2023786144165188N/A
3/31/2023805143168192N/A
12/31/2022825143171196N/A
9/30/2022808124179204N/A
6/30/2022791104188212N/A
3/31/202275894148186N/A
12/31/202172584107160N/A
9/30/202169886108171N/A
6/30/202167188109181N/A
3/31/20216197791157N/A
12/31/20205686673133N/A
9/30/20205416042121N/A
6/30/20205085023105N/A
3/31/20205145521107N/A
12/31/20195226013111N/A
9/30/2019514631693N/A
6/30/2019504662892N/A
3/31/2019497693589N/A
12/31/2018489716294N/A
9/30/2018484716388N/A
6/30/2018483715781N/A
3/31/201848371N/A88N/A
12/31/201747871N/A83N/A
9/30/201747370N/A81N/A
6/30/201747370N/A65N/A
3/31/201747270N/A63N/A
12/31/201647470N/A79N/A
9/30/201647071N/A83N/A
6/30/201645271N/A92N/A
3/31/201643270N/A91N/A
12/31/201541169N/A73N/A
9/30/201539669N/A86N/A
6/30/201538968N/A79N/A
3/31/201538268N/A94N/A
12/31/201437568N/A93N/A
9/30/201436389N/A66N/A
6/30/201435387N/A83N/A
3/31/201434786N/A71N/A
12/31/201334185N/A71N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: 02M1's forecast earnings growth (12.6% per year) is above the savings rate (0.8%).

Guadagni vs Mercato: 02M1's earnings (12.6% per year) are forecast to grow slower than the German market (20.1% per year).

Guadagni ad alta crescita: 02M1's earnings are forecast to grow, but not significantly.

Ricavi vs Mercato: 02M1's revenue (4% per year) is forecast to grow slower than the German market (5.5% per year).

Ricavi ad alta crescita: 02M1's revenue (4% per year) is forecast to grow slower than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: 02M1's Return on Equity is forecast to be low in 3 years time (7.3%).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y